[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100578363":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":22,"responsibleParty":40,"collaborators":43,"id":47,"slug":48,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":49,"sex":55,"minAge":7,"maxAge":7,"enrollmentInfo":56,"targetDuration":7,"studyType":59,"phases":7,"briefSummary":60,"conditions":61,"keywords":7,"overallStatus":24,"whyStopped":7,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"University of Virginia","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Yun M Shim, MD","Division of Pulmonary and Critical Medicine","PRINCIPAL_INVESTIGATOR",[14,19],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Roselove NUNOO-ASARE, MA","CONTACT","434-243-6074","RNN3B@VIRGINIA.EDU",{"name":20,"role":16,"phone":7,"phoneExt":7,"email":21},"Carol Bampoe, BS","cb3ff@virginia.edu",[23],{"facility":5,"status":24,"city":25,"state":26,"zip":27,"country":28,"countryCode":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":36},"RECRUITING","Charlottesville","Virginia","22903","United States","US",{"type":31,"coordinates":32},"Point",[33,34],-78.47668,38.02931,{"lat":34,"lon":33},[37,39],{"name":38,"role":16,"phone":17,"phoneExt":7,"email":18},"Roselove Nunoo-Asare, MA",{"name":10,"role":12,"phone":7,"phoneExt":7,"email":7},{"type":12,"investigatorFullName":41,"investigatorTitle":42,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Y. Michael Shim, MD","Professor, Medicine-Pulmonary and Critical Care Medicine",[44],{"name":45,"class":46},"Barron Associates, Inc.","INDUSTRY","100578363","the-roam-research-study-therapy-ltot-version-100578363",false,"NCT06810323","The ROAM Research Study Therapy (LTOT) Version","The Respiratory Oxygen Adherence Monitor System for COPD With Long Term Oxygen Therapy","ROAM","Inclusion Criteria:\n\nPost-Bronchodilator FEV1\u002FFVC \\\u003C.80\n\n* Race demographics of the recruitment area reflect the population of the Charlottesville Metropolitan Statistical Area (MSA).\n* Due to underrepresentation in local demographics, special effort (via targeted advertising) will be made to recruit Hispanic participants to better match national percentages.\n* Participants with medical history of COPD\n* Subjects has to have a prescription for oxygen use via nasal cannula or mask at home\n* At baseline of health with no hospitalization\u002Fexacerbation within the past 6 weeks\n* Use of Continuous oxygen at baseline\n\nExclusion Criteria:\n\nPost -Bronchodilator FEV1 \\\u003C 25%\n\n* Intermittent oxygen use at home\n* Inability to understand simple instructions\n* No respiratory infections and exacerbation within 6 weeks of study","ALL",{"count":57,"type":58},100,"ESTIMATED","OBSERVATIONAL","The purpose of this research is to test a device being developed that can see how patients use oxygen therapy over a long period of time. This study will focus on developing a new display part called ROAM module which will be attached to your oxygen source. The display will provide easily-accessible information that can show how you interact with your supplies and the oxygen machine automatically without connecting the oxygen source to the internet or other devices.",[62],"Pulmonary Disease, Chronic Obstructive","2025-01-30",{"date":65,"type":66},"2025-02-05","ACTUAL",{"date":68,"type":66},"2025-01-14",{"date":70,"type":58},"2030-12",{"name":5,"class":6},1]